Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)

Mise à jour : Il y a 4 ans
Référence : NCT00160082

Femme et Homme

  • | Pays :
  • Sweden
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective was to assess the effect of Xepol compared to placebo on physical health and on muscle strength in subjects with post-polio syndrome.The secondary objective was to assess the effect of Xepol compared to placebo on functional balance, activity patterns, pain, fatigue, sleep, vitality, muscular strength, pulmonary capacity, walking ability, balance and safety.


Critère d'inclusion

  • Post Polio Syndrome, PPS

Liens